RFK Jr. changes rules to select CDC vaccine advisors after legal setback
2026-04-08 10:13:31 ET
More on Pfizer, GSK, etc.
- GSK: Chinese Expansion And Fine Financials
- Merck: Aggressive M&A Efforts To Prepare For A Keytruda Patent Cliff
- Pfizer: Why Wall Street Habitually Overestimates Target Price
- GSK gets China approval for Exdensur in nasal polyps, expanding respiratory portfolio
- Merck begins tender offer to buy Terns Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
RFK Jr. changes rules to select CDC vaccine advisors after legal setbackNASDAQ: PFE
PFE Trading
0.74% G/L:
$27.4216 Last:
12,588,897 Volume:
$27.21 Open:



